Stocks
ResMed (RMD) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 162.5% | 214.7% | 214.7% | 267.7% | 267.7% | 333.8% | |||
| Changes by years, y/y, % | +52pp | 0pp | +53pp | 0pp | +2.8% | ||||
ResMed. R&D/CAPEX, %
ResMed. R&D/CAPEX, changes, pp
ResMed (RMD) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2024Q3 | 2024Q3 | 2024Q4 | 2024Q4 | 2025Q1 | LTM ? | |||
| R&D/CAPEX, % | 333.5% | 307.2% | 307.2% | 405.6% | 333.8% | |||
| Changes by years, y/y, % | -245pp | +89pp | +105pp | +105pp | +220pp | |||
| Changes by quarters, q/q, % | -301pp | -26pp | 0pp | +98pp | ||||
